Timothy Baumgartner
Papers
1
Total Citations
33
H-Index
1
About
Dr. Timothy Baumgartner is a urologic surgeon and clinical researcher whose work centers on optimizing perioperative pain management and enhancing recovery after laparoscopic urologic surgery. His most impactful contribution is a landmark randomized controlled trial comparing standard 0.25% bupivacaine against long-acting liposomal bupivacaine for pain control in laparoscopic procedures. This study, which has garnered 33 citations, directly addressed a critical clinical and economic question: whether the significantly higher cost of liposomal bupivacaine is justified by superior analgesia. By providing rigorous, prospective evidence on the comparative efficacy of these local anesthetics, Dr. Baumgartner’s research has helped guide evidence-based prescribing decisions, potentially reducing unnecessary healthcare expenditures without compromising patient comfort. His work exemplifies the integration of clinical trial methodology into everyday surgical practice, offering practical insights for urologists seeking to balance cost-effectiveness with high-quality postoperative care. Through this focused investigation, Dr. Baumgartner has established himself as a thoughtful contributor to the fields of urologic surgery and enhanced recovery after surgery (ERAS) protocols.
Research Focus
Key Achievements
Top Papers
- 1